BioWatch: Dendreon Looks Even Brighter (DNDN)
Earlier this week, we highlighted Dendreon Corporation (NASDAQ: DNDN) as one of five biotechs with 50% implied upside. A new report is out from Canaccord Genuity that has figures which ...Read Full Story »














